SAFETY AND EFFICACY OF EZETIMIBE/SIMVASTATIN COMBINATION VERSUS ATORVASTATIN IN PATIENTS 65 YEARS OF AGE AND OLDER

被引：0
|
作者：
Foody, J. M. [1 ]
Brown, W. V. [2 ]
Zieve, F. [3 ,4 ]
Adewale, A. J. [5 ]
Flaim, D. [5 ]
Lowe, R. S. [5 ]
Jones-Burton, C. [5 ]
Tershakovec, A. M. [5 ]
机构：
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[3] McGuire VA Med Ctr, Richmond, VA USA
[4] Virginia Commonwealth Univ, Richmond, VA USA
[5] Merck & Co Inc, N Wales, PA USA
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2010年 / 11卷 / 02期
关键词：
D O I：
10.1016/S1567-5688(10)70344-5
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P277
引用
收藏
页码：75 / 76
页数：2
相关论文
共 50 条
  • [31] Retrospective study on antihyperlipidemic efficacy and safety of simvastatin, ezetimibe and their combination in Korean adults
    Young-Hee Lee
    Mi-Jeong Kim
    Chang-Ik Choi
    Jung-Woo Bae
    Choon-Gon Jang
    Seok-Yong Lee
    Archives of Pharmacal Research, 2011, 34 : 1331 - 1337
  • [32] Efficacy and safety of combination tokultraphi/atorvastatin versus atorvastatin alone in patients with heterozygous familial hypercholesterolemia
    Revkin, J. H.
    Ose, L.
    Marais, A. D.
    Pretorius, M.
    Viljoen, I.
    Burgess, L.
    Lan, S. P.
    Thuren, T.
    Shear, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 203 - 203
  • [33] Efficacy and safety of combination torcetrapib/atorvastatin versus atorvastatin alone in patients with heterozygous familial hypercholesterolemia
    Revkin, James
    Ose, Leiv
    Marais, A. David
    Pretorius, Matty
    Viljoen, Johann
    Burgess, Lesley
    Lan, Shu-Ping
    Thuren, Tom
    Shear, Charles
    CIRCULATION, 2006, 114 (18) : 318 - 318
  • [34] The comparative efficacy of ezetimibe added to atorvastatin 10 mg versus uptitration to atorvastatin 40 mg in subgroups of patients aged 65 to 74 years or greater than or equal to 75 years
    Ben-Yehuda, Ori
    Wenger, Nanette K.
    Constance, Christian
    Zieve, Franklin
    Hanson, Mary E.
    Lin, Jian-Xin
    Shah, Arvind K.
    Jones-Burton, Charlotte
    Tershakovec, Andrew M.
    JOURNAL OF GERIATRIC CARDIOLOGY, 2011, 8 (01) : 1 - 11
  • [35] Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older
    Li, Daniel
    Mccaw, Zachary R.
    Wei, Lee-Jen
    JAMA CARDIOLOGY, 2020, 5 (02) : 235 - 235
  • [36] EFFICACY AND SAFETY OF FENOFIBRIC ACID IN COMBINATION WITH ATORVASTATIN AND EZETIMIBE IN PATIENTS WITH MIXED DYSLIPIDEMIA: A PHASE 3 STUDY
    Jones, P.
    Goldberg, A.
    Knapp, H.
    Kelly, M.
    Setze, C.
    Stolzenbach, J.
    Sleep, D.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [37] Comparison of the efficacy and safety of atorvastatin with simvastatin in patients with primary hypercholesterolemia
    Black, DM
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 120 - 120
  • [38] Efficacy and safety of ezetimibe plus atorvastatin therapy
    Foody, JoAnne M.
    Toth, Peter P.
    Tershakovec, Andrew M.
    Musliner, Thomas
    Tomassini, Joanne E.
    Lowe, Robert S.
    Neff, David R.
    Davis, Harry R.
    CLINICAL LIPIDOLOGY, 2014, 9 (04) : 441 - 470
  • [39] Effects of simvastatin, atorvastatin, ezetimibe, and ezetimibe plus simvastatin combination on the inflammatory process and on the liver metabolic changes of arthritic rats
    Bracht, Livia
    Barbosa, Carmem Patricia
    Caparroz-Assef, Silvana Martins
    Nakamura Cuman, Roberto Kenji
    Ishii-Iwamoto, Emy Luiza
    Bracht, Adelar
    Bersani-Amado, Ciomar Aparecida
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 (06) : 722 - 734
  • [40] Efficacy and safety of atorvastatin versus simvastatin in type II diabetes patients with coronary heart disease
    März, W
    Wollschläger, H
    Klein, G
    Neiss, A
    Wehling, M
    DIABETOLOGIA, 1999, 42 : A19 - A19
12345